Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy
In December 2019, Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2, occurred in China and has currently led to a global pandemic. In addition to respiratory involvement, COVID-19 was also associated with significant multiple organ dysfunction syndrome (MODS). Cardiovascular impairment has be...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020-04-01
|
| coleção: | Frontiers in Cardiovascular Medicine |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/article/10.3389/fcvm.2020.00078/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|